Verastem (VSTM) Price to FCF (2012 - 2026)
Powered by 
Analysis
Verastem (VSTM) Price to FCF (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Verastem | 813.50 Mn | 677.15 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.87 |
| Mar 31, 2026 | -8.93 |
| Dec 31, 2025 | -20.04 |
| Sep 30, 2025 | -16.27 |
| Jun 30, 2025 | -7.82 |
| Mar 31, 2025 | -8.03 |
| Dec 31, 2024 | -7.36 |
| Sep 30, 2024 | -5.06 |
| Jun 30, 2024 | -2.90 |
| Mar 31, 2024 | -10.54 |
| Dec 31, 2023 | -6.93 |
| Sep 30, 2023 | -12.38 |
| Jun 30, 2023 | -6.63 |
| Mar 31, 2023 | -4.15 |
| Dec 31, 2022 | -4.83 |
| Sep 30, 2022 | -11.84 |
| Jun 30, 2022 | -17.14 |
| Mar 31, 2022 | -13.63 |
| Dec 31, 2021 | -38.24 |
| Sep 30, 2021 | -51.82 |